Tesamorelin vs CJC-1295.
Side-by-side research comparison of Tesamorelin and CJC-1295: dosing, half-life, side effects, and mechanism of action.
Quick Verdict
Tesamorelin for aggressive visceral fat loss (FDA-approved, ~18% VAT reduction at 26 weeks). CJC-1295 for sustainable long-term GH optimization covering anti-aging, sleep, and body recomposition. Tesamorelin is stronger; CJC-1295 is more versatile and affordable.
Side-by-Side Analysis
| Dimension | Tesamorelin | CJC-1295 |
|---|---|---|
| Mechanism | Stimulates GH for fat metabolism. | Stimulates prolonged GH and IGF-1 release by mimicking the body's natural GHRH signal to the pituitary gland. |
| Primary Benefits | Visceral fat reduction, body recomposition | Muscle growth, fat loss, recovery |
| Typical Dose | 1000–1000mcg | 1000–1000mcg |
| Route | SubQ | SubQ |
| Frequency | 7x/week | 3x/week |
| Half-Life | 0.43 hours | 168 hours |
| FDA Status | Approved | Approved |
| Evidence Grade | very-strong | moderate |
| Key Studies | 20+ indexed | 20+ indexed |
| Lowest Price | $69.99 / 10mg via Amino Club | $59.99 / 10mg via Amino Club |
Which one should you choose?
Who Should Choose Tesamorelin?
Choose Tesamorelin if you:
- Have significant visceral (abdominal) fat accumulation to target
- Are researching metabolic syndrome or lipodystrophy specifically
- Want the largest acute GH spike for maximum lipolysis
- Are comfortable with a more potent, higher-cost GHRH analog
Who Should Choose CJC-1295?
Choose CJC-1295 if you:
- Want a versatile, affordable long-term GH optimization protocol
- Are prioritizing anti-aging, sleep, and lean mass alongside fat loss
- Plan to stack with Ipamorelin for synergistic GH output
- Are newer to GHRH analogs and want a more manageable starting point
Can you stack Tesamorelin + CJC-1295?
Both pair with Ipamorelin (GHRP) for synergistic GH amplification. Do NOT combine Tesamorelin + CJC-1295 together — they target the same GHRH receptor redundantly. Choose one GHRH analog and pair it with Ipamorelin.
Vendor Pricing
· Affiliate links · Prices verified 2026Tesamorelin
3 vendorsCJC-1295
1 vendorAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
Yes, decisively. Tesamorelin's FDA-approval was specifically for visceral adipose tissue reduction. The LIPO-010 clinical trial showed ~18% VAT reduction after 26 weeks at 2mg/day. CJC-1295 can reduce fat via GH-driven lipolysis but lacks this targeted visceral fat clinical evidence.
Related Comparisons
Deep Dive Profiles
Research Tools
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.